Triphase Pharmaceuticals

Mysuru, India
Offers comprehensive solutions in probiotic products, animal nutrition, and ingredients.

About Triphase Pharmaceuticals

Triphase Pharmaceuticals was a Healthcare company based in Mysuru (India). It offers comprehensive solutions in probiotic products, animal nutrition, and ingredients. It operates on a B2B model. The company has 12 employees. Triphase Pharmaceuticals has completed 1 acquisition, including Nereus Pharmaceuticals. Its Indian entity Triphase Pharmaceuticals Private Limited reported revenue of β‚Ή6 Lakh. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Nutraceuticals and Probiotic Products.

Company details

Triphase Pharmaceuticals operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, nutraceuticals, and probiotic products. Offers comprehensive solutions in probiotic products, animal nutrition, and ingredients. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Key Metrics
  • Annual Revenue
    ₹6 Lakh

    FY 2022 · +233% YoY

  • Net Loss
    -₹3.36 Cr

    FY 2022 · -5572% margin

  • EBITDA
    -₹2.30 Cr

    FY 2022 · -3817% margin

  • Employee Count
    12
  • Investments & Acquisitions

Board of directors of Triphase Pharmaceuticals Private Limited (Triphase Pharmaceuticals)

Triphase Pharmaceuticals Private Limited is the primary company behind Triphase Pharmaceuticals. The boards of the 2 registered companies of Triphase Pharmaceuticals currently have 7 directors; the longest-serving is Venkataraman Subramanian Iyer, appointed in 2007. 23 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Venkataraman Subramanian Iyer
DIN 00408092
Director02 Apr 200719 yrs 7 moInstapill Private Limited
Guruswamy Pendyala
DIN 01880807
Whole-time director28 Apr 20179 yrs 6 moInstapill Private Limited
Perumal Manoharan
DIN 09072766
Director02 Mar 20233 yrs 8 moTriphase Pharmaceuticals Private Limited
Aditya Desiraju
DIN 01158393
Director02 Mar 20233 yrs 8 moTriphase Pharmaceuticals Private Limited
Ankit Gupta
DIN 08015587
Whole-time director11 Feb 20251 yr 9 moInstapill Private Limited
Rajashri Santosh Kumar Ojha
DIN 07058128
Director11 Feb 20251 yr 9 moInstapill Private Limited
Gopakumar Gopalan Nair
DIN 00092637
Director11 Feb 20251 yr 9 moInstapill Private Limited

Financials of Triphase Pharmaceuticals

Figures of Triphase Pharmaceuticals Private Limited, the primary company behind Triphase Pharmaceuticals, for FY 2022. Revenue was ₹6 Lakh (+233% year on year). Net loss was -₹3.36 Cr (-5572% margin). EBITDA was -₹2.30 Cr (-3817% margin). Revenue has grown at a compounded annual rate of +107% over three years and -19% over five years.

  • ₹6 LakhRevenue · FY 2022 · +233% YoY
  • -₹3.36 CrNet loss · -5572% margin
  • -₹2.30 CrEBITDA · -3817% margin
  • ₹12.5 LakhPaid-up capital
  • 12Employees (provident fund records)
  • +107%Revenue CAGR, 3 years
  • -19%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Triphase Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Triphase Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Triphase Pharmaceuticals

Triphase Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Nereus Pharmaceuticals.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Develop therapeutics for the treatment of oncology, infectious diseases and inflammation
nereuspharm.comSan Diego, United States1998Oct 2012β€’β€’β€’β€’
Premium access

Complete acquisition details for Triphase Pharmaceuticals

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Top companies in Nutraceutical & Food-as-Medicine Platforms

3 companies that operate in the same segment as Triphase Pharmaceuticals (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Ayurvedic healthcare and nutritional products are provided by Kapiva.
2016Bengaluru, Karnataka, IndiaUSD 77.85 MUSD 55.41 M362
Nutritional supplements for multiple health ailments are developed.
2005Mumbai, Maharashtra, IndiaUSD 1.55 M
Nutritional food and health supplements are provided by OZiva.
2010Mumbai, Maharashtra, IndiaUSD 17.32 MUSD 56.21 M144
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Triphase Pharmaceuticals

Triphase Pharmaceuticals is headquartered in Mysuru, India. It is registered at Mysuru, Karnataka, India.

Triphase Pharmaceuticals has 12 employees.

The primary company behind Triphase Pharmaceuticals, Triphase Pharmaceuticals Private Limited, reported revenue of β‚Ή6 Lakh for FY 2022, up 233% year on year.

Triphase Pharmaceuticals operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, nutraceuticals, and probiotic products. Offers comprehensive solutions in probiotic products, animal nutrition, and ingredients. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Triphase Pharmaceuticals has made 1 acquisition, including Nereus Pharmaceuticals.

Triphase Pharmaceuticals is associated with 2 legal entities: Triphase Pharmaceuticals Private Limited, Instapill Private Limited.

The legal entities of Triphase Pharmaceuticals currently have 8 directors, including Ankit Gupta, Venkataraman Subramanian Iyer, Rajashri Santosh Kumar Ojha and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available